Everence Capital Management Inc. Has $287,000 Stock Holdings in Select Medical Holdings Co. (NYSE:SEM)

Everence Capital Management Inc. lessened its holdings in Select Medical Holdings Co. (NYSE:SEM) by 9.7% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 15,210 shares of the health services provider’s stock after selling 1,630 shares during the quarter. Everence Capital Management Inc.’s holdings in Select Medical were worth $287,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also modified their holdings of the business. Quarry LP bought a new stake in Select Medical in the 3rd quarter valued at about $30,000. Canada Pension Plan Investment Board acquired a new stake in Select Medical during the second quarter worth approximately $39,000. DekaBank Deutsche Girozentrale bought a new position in Select Medical during the 2nd quarter worth $60,000. GAMMA Investing LLC raised its holdings in Select Medical by 16.6% in the 3rd quarter. GAMMA Investing LLC now owns 2,313 shares of the health services provider’s stock valued at $81,000 after acquiring an additional 330 shares in the last quarter. Finally, Wilmington Savings Fund Society FSB bought a new stake in shares of Select Medical during the 3rd quarter valued at $81,000. 89.48% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

SEM has been the topic of several recent analyst reports. Royal Bank of Canada raised their target price on shares of Select Medical from $40.00 to $47.00 and gave the company an “outperform” rating in a report on Monday, November 4th. UBS Group cut their target price on Select Medical from $40.00 to $21.00 and set a “neutral” rating for the company in a research note on Friday, January 3rd. StockNews.com upgraded Select Medical from a “hold” rating to a “buy” rating in a research note on Tuesday. Finally, Benchmark downgraded Select Medical from a “buy” rating to a “hold” rating in a research report on Monday, November 25th. Two equities research analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $39.50.

Select Medical Stock Up 1.3 %

Shares of NYSE:SEM opened at $18.65 on Wednesday. Select Medical Holdings Co. has a 52-week low of $18.02 and a 52-week high of $40.98. The company has a market capitalization of $2.41 billion, a PE ratio of 8.71, a price-to-earnings-growth ratio of 0.39 and a beta of 1.45. The company has a debt-to-equity ratio of 1.37, a quick ratio of 1.13 and a current ratio of 1.13. The company has a fifty day moving average of $26.63 and a 200-day moving average of $32.08.

Select Medical (NYSE:SEM) last released its quarterly earnings data on Thursday, October 31st. The health services provider reported $0.43 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.36 by $0.07. The company had revenue of $1.76 billion during the quarter, compared to the consensus estimate of $1.74 billion. Select Medical had a return on equity of 15.99% and a net margin of 3.97%. The firm’s revenue was up 5.7% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.46 earnings per share. On average, equities analysts predict that Select Medical Holdings Co. will post 1.97 EPS for the current fiscal year.

Select Medical Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, November 26th. Stockholders of record on Wednesday, November 13th were given a $0.125 dividend. The ex-dividend date of this dividend was Wednesday, November 13th. This represents a $0.50 dividend on an annualized basis and a dividend yield of 2.68%. Select Medical’s dividend payout ratio (DPR) is currently 23.36%.

Insider Activity at Select Medical

In related news, VP Robert G. Breighner, Jr. sold 4,989 shares of Select Medical stock in a transaction on Wednesday, December 4th. The shares were sold at an average price of $19.95, for a total value of $99,530.55. Following the completion of the sale, the vice president now owns 30,356 shares of the company’s stock, valued at approximately $605,602.20. This trade represents a 14.12 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Marilyn B. Tavenner sold 32,000 shares of the business’s stock in a transaction dated Tuesday, November 26th. The stock was sold at an average price of $21.09, for a total transaction of $674,880.00. Following the sale, the director now directly owns 22,000 shares of the company’s stock, valued at approximately $463,980. The trade was a 59.26 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 19.14% of the stock is owned by company insiders.

About Select Medical

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.